Labiotech.eu - Europe's leading Biotech News Website

Latest Posts

News and Trends 22 Jan 2016

Biotech of the week: Medicago, Your Trusted Partner in Biotech

This week we leave Amsterdam behind and move North East across Denmark, to Sweden and more precisely, Uppsala, the location of the biotech of the week, Medicago. This week, we even have a special discount for Labiotech’s reader who want to order a product from Medicago (see at the end of the article)! City: Uppsala, Sweden […]

January 22, 2016 - 2 minutesmins - By Jerome Topsent

News and Trends 21 Jan 2016

Mologen Joins the Rapidly Growing List of EU Partners with the No#1 US Cancer Hospital

MD Anderson (US) and the Berlin Biotech Mologen (Germany) have now partnered on for an Immuno-Oncology program fighting colorectal and small-cell lung carcinoma. The University of Texas MD Anderson Cancer Center is ‘One of the world’s most respected centres‘ devoted exclusively to cancer patient care, research, education and prevention. Having partnered with various European research institutions, medical centres […]

January 21, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 21 Jan 2016

Fighting Lupus with an Autoimmune Disease Vaccine that Uses Limpet Proteins

Neovacs in Paris (France) investigates immunotherapies for the treatment of autoimmune diseases and today signed a partnering agreement with the molluscan protein manufacturer, Stellar Biotechnologies (US). This joint venture will operate under the name of Neostell SAS, and it will be owned 30:70, the majority going to Neovacs. Neovacs is a biotech focused on an active immunotherapy technology platform (Kinoids) […]

January 21, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 20 Jan 2016

Swiss Biotech Merger: Bones + Oncology + Vaccines?

Kuros Biosurgery in Zürich (Switzerland), the bone remodelling biotech for trauma patients, today officially acquired Cytos Biotechnology in Schlieren, the two of which are now to be rebranded ‘Kuros Biosciences’ in a Swiss Stock Exchange merger. Kuros is developing innovative products for tissue repair and regeneration. The company is a spin-off of the Swiss Federal […]

January 20, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 20 Jan 2016

How is Using Amoeba to Fight off Legionella in Water Tanks a White Biotech Solution?

A French Green-Biocide Specialist, Amoéba (France) is using these voracious single celled predators to tackle water-borne diseases, with added help from the Toulouse White Biotech (TWB). Toulouse White Biotechnology (TWB), a pre-industrial demonstrator, and Amoéba have been working together for nearly 18 months in order to produce a revolutionary biocide (using living amoeba). This biocide would […]

January 20, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 19 Jan 2016

Microbiome Myth Debunked: Counting Bacteria in Our Gut = A New Ratio

As reported in Nature, new data has completely contradicted the universally accepted rule than the number of bacteria within our guts greatly outnumbers the number of our own cells.Why? The long standing belief in Biology has been solid on the ratio of Microbes, viruses and human cells within our bodies. However, researchers Ron Milo and […]

January 19, 2016 - 3 minutesmins - By Dani Bancroft

ADVERTISEMENT

News and Trends 19 Jan 2016

Novozymes Spawn World’s First Recombinant Albumin Biotech in Denmark

Novozymes in Bagsværd (Denmark) has just announced it has separated its biopharma activities into an independent company, called Albumedix. Novozymes is almost purely industrial biotech, as the World’s leading enzyme manufacturer. However, they also have some expertise in Health, which has now budded off (like yeast!) to become a wholly owned subsidiary, Albumedix. Albumedix is […]

January 19, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 19 Jan 2016

Top 8 Deadliest Cancers and their Potential Cures

With more than 200 types of cancer, the possibility of developing a Universal Cure is in reality, a myth. However, the fight against the World’s Deadliest Cancers is far from being lost…and there lies hope in the Biotech Industry. Simply by having a quick look through our articles, we can easily confirm that cancer is […]

January 19, 2016 - 7 minutesmins - By Dani Bancroft

News and Trends 18 Jan 2016

Where there be Patent-Free Markets: Swiss-Swedish Biosimilar for Blindess Reaches Iran

Helvetic BioPharma (Switzerland) estimates that 70,000 people suffer from age-related macular degeneration in Iran, the leading cause of blindness. This deal with Xbrane in Stockholm (Sweden) will debut a biosimilar therapy that could really tackle this problem. Xbrane itself is a Swedish biopharma with links to Italy (after an acquisition of the Italian Primm Pharma […]

January 18, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 18 Jan 2016

Inside Biotech’s Most Secretive Elite Conference: MorphoSys Talks on Investor Speed Dating in California

MorphoSys is the Biggest Biotech in Germany, and second biggest in Europe – so it is no wonder they were selected for access to the exclusive J.P.Morgan Conference in San-Francisco last week. Here, the MorphoSys team, which included Claudia Gutjahr-Löser and the CEO Simon Moroney, give you a sneak-insiders look into one of the most elite Biotech […]

January 18, 2016 - 4 minutesmins - By Philip Hemme

News and Trends 16 Jan 2016

What happened this week? 10 Hot EU Biotechs, J.P. Morgan and a Surprise

Monday: How about the $100M Holy ‘GRAIL’ in Cancer Diagnostics? A Universal Test Start-up Faces German Competition Tuesday: 10 Hot European Biotechs to watch in 2016 Wednesday: UK Biotech starts 2016 by signing a (Massive?) Immuno-Oncology Deal with AbbVie Thursday: The Biotech World is Buzzing: J.P. Morgan’s 2016 Phenomenon Kicks off this Week! Friday: Faces […]

January 16, 2016 - 1 minutemin - By Philip Hemme

News and Trends 15 Jan 2016

Faces of BioArt: Eduardo Kac and His Transgenic Organisms

Last week I talked about my experience meeting Susanna Hertrich at the Art Laboratory Berlin, and now I move to Eduardo Kac, who actually coined the term ‘BioArt’. As a US-Brazilian from Rio, Eduardo has developed a global reputation as a ‘Transgenic Artist‘. One of Eduardo Kac‘s most famous pieces, ‘Genesis‘ (1999), was a transgenic […]

January 15, 2016 - 2 minutesmins - By Dani Bancroft

ADVERTISEMENT